• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抑制性受体LILRB1调节人树突状细胞的分化和调节潜能。

The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells.

作者信息

Young Neil T, Waller Edward C P, Patel Rashmi, Roghanian Ali, Austyn Jonathan M, Trowsdale John

机构信息

Division of Immunology, Department of Pathology, University of Cambridge, Cambridge, UK.

出版信息

Blood. 2008 Mar 15;111(6):3090-6. doi: 10.1182/blood-2007-05-089771. Epub 2007 Dec 19.

DOI:10.1182/blood-2007-05-089771
PMID:18094328
Abstract

Dendritic cells (DCs) link innate and adaptive immunity, initiating and regulating effector cell responses. They ubiquitously express members of the LILR (ILT, LIR, CD85) family of molecules, some of which recognize self-HLA molecules, but little is known of their possible functions in DC biology. We demonstrate that the inhibitory receptor LILRB1 (ILT2, LIR1, CD85j) is selectively up-regulated during DC differentiation from monocyte precursors in culture. Continuous ligation of LILRB1 modulated cellular differentiation, conferred a unique phenotype upon the resultant cells, induced a profound resistance to CD95-mediated cell death, and inhibited secretion of cytokines IL-10, IL-12p70, and TGF-beta. These features remained stable even after exposure of the cells to bacterial LPS. Ligated DCs exhibited poor stimulatory activity for primary and memory T-cell proliferative responses, but this was substantially reversed by blockade of CD80 or its preferred ligand CTLA-4, or by depleting CD4(+) CD25(+) CD127(lo) regulatory T cells. Our findings suggest that ligation of LILRB1 on DCs by self-HLA molecules may play a key role in controlling the balance between the induction and suppression of adaptive immune responses.

摘要

树突状细胞(DCs)连接先天性免疫和适应性免疫,启动并调节效应细胞反应。它们普遍表达LILR(ILT、LIR、CD85)分子家族的成员,其中一些成员可识别自身HLA分子,但对其在DC生物学中的潜在功能知之甚少。我们证明,抑制性受体LILRB1(ILT2、LIR1、CD85j)在培养的单核细胞前体向DC分化过程中被选择性上调。LILRB1的持续连接调节细胞分化,赋予所得细胞独特的表型,诱导对CD95介导的细胞死亡产生深刻抗性,并抑制细胞因子IL-10、IL-12p70和TGF-β的分泌。即使在细胞暴露于细菌脂多糖后,这些特征仍保持稳定。被连接的DC对初始和记忆性T细胞增殖反应的刺激活性较差,但通过阻断CD80或其首选配体CTLA-4,或通过消耗CD4(+) CD25(+) CD127(lo)调节性T细胞,这种情况可得到显著逆转。我们的研究结果表明,自身HLA分子对DC上LILRB1的连接可能在控制适应性免疫反应的诱导和抑制之间的平衡中起关键作用。

相似文献

1
The inhibitory receptor LILRB1 modulates the differentiation and regulatory potential of human dendritic cells.抑制性受体LILRB1调节人树突状细胞的分化和调节潜能。
Blood. 2008 Mar 15;111(6):3090-6. doi: 10.1182/blood-2007-05-089771. Epub 2007 Dec 19.
2
HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j.HLA I类分子通过抑制性受体ILT2/CD85j调节靶细胞、病毒产物或未成熟树突状细胞在自然杀伤细胞中诱导产生的γ干扰素。
J Immunol. 2008 Aug 15;181(4):2368-81. doi: 10.4049/jimmunol.181.4.2368.
3
Dual effect of CD85/leukocyte Ig-like receptor-1/Ig-like transcript 2 and CD152 (CTLA-4) on cytokine production by antigen-stimulated human T cells.CD85/白细胞免疫球蛋白样受体-1/免疫球蛋白样转录本2和CD152(细胞毒性T淋巴细胞相关抗原4)对抗原刺激的人T细胞产生细胞因子的双重作用。
J Immunol. 2002 Jan 1;168(1):207-15. doi: 10.4049/jimmunol.168.1.207.
4
Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1beta, and the production of interferon gamma in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses.Fas 激活可诱导树突状细胞(DCs)成熟、白细胞介素(IL)-1β 释放,并在 DC 与 T 细胞同源相互作用期间在缺乏 IL-12 的情况下诱导干扰素 γ 产生:Fas 配体在炎症反应中的新作用。
J Exp Med. 2000 Dec 4;192(11):1661-8. doi: 10.1084/jem.192.11.1661.
5
CD85j (leukocyte Ig-like receptor-1/Ig-like transcript 2) inhibits human osteoclast-associated receptor-mediated activation of human dendritic cells.CD85j(白细胞免疫球蛋白样受体-1/免疫球蛋白样转录物2)抑制人破骨细胞相关受体介导的人树突状细胞活化。
J Immunol. 2005 Jun 1;174(11):6757-63. doi: 10.4049/jimmunol.174.11.6757.
6
Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4.饱和脂肪酸和多不饱和脂肪酸相互调节通过Toll样受体4(TLR4)介导的树突状细胞功能。
J Immunol. 2005 May 1;174(9):5390-7. doi: 10.4049/jimmunol.174.9.5390.
7
Alternative mRNA splicing creates transcripts encoding soluble proteins from most LILR genes.可变剪接从大多数 LILR 基因产生编码可溶性蛋白的转录本。
Eur J Immunol. 2009 Nov;39(11):3195-206. doi: 10.1002/eji.200839080.
8
Immunomodulatory Effects of Four Leishmania infantum Potentially Excreted/Secreted Proteins on Human Dendritic Cells Differentiation and Maturation.四种婴儿利什曼原虫潜在排泄/分泌蛋白对人树突状细胞分化和成熟的免疫调节作用
PLoS One. 2015 Nov 18;10(11):e0143063. doi: 10.1371/journal.pone.0143063. eCollection 2015.
9
Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2.可溶性 HLA-G 通过与白细胞免疫球蛋白样受体 B2 相互作用抑制 HIV-1 感染中的髓样树突状细胞功能。
J Virol. 2010 Oct;84(20):10784-91. doi: 10.1128/JVI.01292-10. Epub 2010 Aug 11.
10
Cyclic nucleotides promote monocyte differentiation toward a DC-SIGN+ (CD209) intermediate cell and impair differentiation into dendritic cells.环核苷酸促进单核细胞向DC-SIGN+(CD209)中间细胞分化,并损害其向树突状细胞的分化。
J Immunol. 2003 Dec 15;171(12):6421-30. doi: 10.4049/jimmunol.171.12.6421.

引用本文的文献

1
Inhibitory leukocyte immunoglobulin-like receptors, subfamily B (LILRBs) in human diseases: structure, roles, mechanisms, and clinical applications.人类疾病中的抑制性白细胞免疫球蛋白样受体B亚家族(LILRBs):结构、作用、机制及临床应用
Theranostics. 2025 Jul 25;15(16):8222-8258. doi: 10.7150/thno.116951. eCollection 2025.
2
The progression of multiple myeloma is regulated by LILRB1 via the GATA2-SAGE1 pathway.多发性骨髓瘤的进展由LILRB1通过GATA2-SAGE1途径调控。
Br J Haematol. 2025 Jul;207(1):69-79. doi: 10.1111/bjh.20144. Epub 2025 May 25.
3
Therapeutic targeting of tumour-associated macrophage receptors.
肿瘤相关巨噬细胞受体的治疗靶向作用
Immunother Adv. 2025 Mar 11;5(1):ltaf009. doi: 10.1093/immadv/ltaf009. eCollection 2025.
4
Psoriasis harbors multiple pathogenic type 17 T-cell subsets: Selective modulation by risankizumab.银屑病存在多种致病性17型T细胞亚群:司库奇尤单抗的选择性调节作用
J Allergy Clin Immunol. 2025 Jun;155(6):1898-1912. doi: 10.1016/j.jaci.2025.02.008. Epub 2025 Feb 18.
5
Leukocyte immunoglobulin-like receptor B1 (LILRB1) protects human multiple myeloma cells from ferroptosis by maintaining cholesterol homeostasis.白细胞免疫球蛋白样受体 B1(LILRB1)通过维持胆固醇稳态来保护人多发性骨髓瘤细胞免受铁死亡。
Nat Commun. 2024 Jul 9;15(1):5767. doi: 10.1038/s41467-024-50073-x.
6
MHC1/LILRB1 axis as an innate immune checkpoint for cancer therapy.MHC1/LILRB1 轴作为癌症治疗的先天免疫检查点。
Front Immunol. 2024 Jun 7;15:1421092. doi: 10.3389/fimmu.2024.1421092. eCollection 2024.
7
Cellular strategies to induce immune tolerance after liver transplantation: Clinical perspectives.肝移植后诱导免疫耐受的细胞策略:临床展望
World J Gastroenterol. 2024 Apr 7;30(13):1791-1800. doi: 10.3748/wjg.v30.i13.1791.
8
Inhibitory receptors of plasmacytoid dendritic cells as possible targets for checkpoint blockade in cancer.浆细胞样树突状细胞的抑制性受体作为癌症检查点阻断治疗的潜在靶点。
Front Immunol. 2024 Mar 5;15:1360291. doi: 10.3389/fimmu.2024.1360291. eCollection 2024.
9
LILRB4 Checkpoint for Immunotherapy: Structure, Mechanism and Disease Targets.LILRB4 免疫疗法检查点:结构、机制和疾病靶点。
Biomolecules. 2024 Feb 4;14(2):187. doi: 10.3390/biom14020187.
10
Sex-biased genetic regulation of inflammatory proteins in the Dutch population.荷兰人群中炎症蛋白的性别偏向性遗传调控。
BMC Genomics. 2024 Feb 8;25(1):154. doi: 10.1186/s12864-024-10065-z.